Case 8:11-cv-01264-CJC -RNB Document 1Filed 08/23/11 Page 1 of 44 Page ID #:1 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 2 of 44 Page ID #:2 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 2. CareFusion delivers clinically proven products and services that help measurably improve patient care in the medical field. Its family of products and services are used in more than 120 countries. 3. With fiscal 2010 pro forma revenue of $3.9 billion, CareFusion Corporation is the largest medical-technology company focused on helping the global healthcare industry solve its most challenging patient safety issues. 4. Defendant is a Pennsylvania corporation with its principal place of business in Bethlehem, Pennsylvania. 5. At all material times hereto, Defendant has manufactured, distributed, marketed, offered for sale and sold products, including but not limited to the infringing ULTRASITE® Capless Valve System and CARESITE® Luer Access Device, in this judicial district and elsewhere in the United States. JURISDICTION AND VENUE 6. This is an action for patent infringement arising under the patent laws of the United States, Title 35 of the United States Code. The Court has federal question jurisdiction under 28 U.S.C. § 1331 and exclusive original jurisdiction under 28 U.S.C. § 1338(a). 7. This Court has personal jurisdiction over Defendant in this action because Defendant, directly and/or indirectly through its subsidiaries and affiliated companies, has engaged in substantial business within this forum amounting to sufficient minimum contacts, including, but not limited to, distributing, marketing, using, selling, and/or offering to sell products and services in California and this juridical district, and employment of personnel within this judicial district. Defendant has operated a manufacturing facility in Irvine, California, within this judicial district, for over 30 years, presently employing over 1000 people. Defendant also has availed itself of the laws of California and previously submitted itself to the jurisdiction of this Court by filing suit in this Court, and has admitted to having sufficient contacts with this jurisdiction for purposes of litigation. See, 2 COMPLAINT FOR PATENT INFRINGEMENT CASE NO. Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 3 of 44 Page ID #:3 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 e.g., Complaint, Dkt. No. 1, B. Braun Medical, Inc. v. Westchester Med. Ctr., Case No. 8:99-cv-01010 (complaint filed August 6, 1999). 8. 1400. COUNT I – INFRINGEMENT OF U.S. PATENT NO. 5,782,816 9. Plaintiff repeats and realleges the allegations of paragraphs 1 through Venue is proper in this district pursuant to 28 U.S.C. §§ 1391 and 8 as if set forth herein. 10. U.S. Patent No. 5,782,816 (“the ’816 Patent”), entitled “Bi- Directional Valve and Method of Using Same,” was duly and legally issued on July 21, 1998, by the United States Patent and Trademark Office. CareFusion 303 has been assigned the entire right, title and interest in the ’816 Patent. A true and correct copy of the ‘816 Patent is attached hereto as Exhibit A. 11. Defendant has infringed and continues to infringe the ’816 Patent by making, using, selling and/or offering to sell within the United States (including within this judicial district) devices that embody the inventions disclosed and claimed in the ’816 Patent, and/or importing into the United States devices that embody the inventions disclosed and claimed in the ’816 Patent, without authorization from CareFusion 303. At least Defendant’s ULTRASITE® Capless Valve System and CARESITE® Luer Access Device directly infringe the claims of the ’816 Patent, in violation of 35 U.S.C. § 271. For example and not limitation, Defendant’s ULTRASITE® and CARESITE® devices practice each of the limitations of at least independent claim 1 of the ’816 Patent. 12. In addition to direct infringement, CareFusion 303 is informed and believes, and on that basis alleges, that Defendant has indirectly infringed and continues to indirectly infringe the ’816 Patent by contributing to infringement by others of the ’816 Patent, and by knowingly inducing others to infringe the ’816 Patent. For example and not limitation, Defendant sells and offers to sell within the United States or imports into the United States devices and/or components of 3 COMPLAINT FOR PATENT INFRINGEMENT CASE NO. Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 4 of 44 Page ID #:4 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 patented devices knowing the same to be especially made or especially adapted for use in an infringement of the ’816 Patent. Such devices and/or components are not staple articles or commodities of commerce, nor are they suitable for substantial noninfringing use. Defendant also actively induces infringement of the ’816 Patent by its customers and/or others, including, for example and not limitation, by providing written instructional documents and instructional videos directing customers to use Defendant’s ULTRASITE® and CARESITE® devices in a manner that directly infringes the ’816 Patent. 13. Further discovery may reveal that Defendant’s infringement of the ’816 Patent has been and continues to be willful. 14. CareFusion 303 has been and will continue to be damaged by Defendant’s infringement of the ’816 Patent and will be irreparably harmed unless that infringement is enjoined. COUNT II – INFRINGEMENT OF U.S. PATENT NO. 5,730,418 15. Plaintiff repeats and realleges the allegations of paragraphs 1 through 14 as if set forth herein. 16. U.S. Patent No. 5,730,418 (“the ’418 Patent”), entitled “Minimum Fluid Displacement Medical Connector,” was duly and legally issued on March 24, 1998, by the United States Patent and Trademark Office. An ex parte reexamination certificate was duly and legally issued by the United States Patent and Trademark Office on April 11, 2006. CareFusion 303 has been assigned the entire right, title and interest in the ’418 Patent. A true and correct copy of the ‘418 Patent is attached hereto as Exhibit B. 17. Defendant has infringed and continues to infringe the ’418 Patent by making, using, selling and/or offering to sell within the United States (including within this judicial district) devices that embody the inventions disclosed and claimed in the ’418 Patent, and/or importing into the United States devices that embody the inventions disclosed and claimed in the ’418 Patent, without 4 COMPLAINT FOR PATENT INFRINGEMENT CASE NO. Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 5 of 44 Page ID #:5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 authorization from CareFusion 303. At least Defendant’s ULTRASITE® Capless Valve System and CARESITE® Luer Access Device directly infringe the claims of the ’418 Patent, in violation of 35 U.S.C. § 271. For example and not limitation, Defendant’s ULTRASITE® and CARESITE® devices practice each of the limitations of at least independent claim 27 of the ’418 Patent. 18. Defendant’s infringement of the ’418 Patent has been and continues to be willful and carried out with full knowledge of the ’418 Patent. Defendant had knowledge of the ’418 Patent not later than early 2006, and was notified that its ULTRASITE® device infringes the ’418 Patent not later than December 20, 2007. 19. CareFusion 303 has been and will continue to be damaged by Defendant’s infringement of the ’418 Patent and will be irreparably harmed unless that infringement is enjoined. PRAYER FOR RELIEF WHEREFORE, Plaintiff respectfully requests the following relief: 1. 2. A judgment that Defendant has infringed the ’816 and ’418 Patents; A permanent injunction issued pursuant to 35 U.S.C. § 283, restraining and enjoining Defendant and its officers, agents, attorneys and employees, and those acting in privity or concert with them, from infringement of the ’816 and ’418 Patents for the full terms thereof; 3. An award of damages to Plaintiff including lost profits and interest thereon, but in any event no less than a reasonable royalty, in an amount adequate to compensate for Defendant’s infringement of the ’816 and ’418 Patents, and, upon a finding of willfulness, that the damages be trebled pursuant to 35 U.S.C. § 284; 4. A declaration that this is an exceptional case and an award of attorney’s fees, disbursements, and costs of this action pursuant to 35 U.S.C. § 285; and, 5. Such other and further relief as the Court may deem just and proper. 5 COMPLAINT FOR PATENT INFRINGEMENT CASE NO. Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 6 of 44 Page ID #:6 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 7 of 44 Page ID #:7 EXHIBIT A Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 8 of 44 Page ID #:8 Exhibit A, Page 7 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 9 of 44 Page ID #:9 Exhibit A, Page 8 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 10 of 44 Page ID #:10 Exhibit A, Page 9 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 11 of 44 Page ID #:11 Exhibit A, Page 10 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 12 of 44 Page ID #:12 Exhibit A, Page 11 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 13 of 44 Page ID #:13 Exhibit A, Page 12 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 14 of 44 Page ID #:14 Exhibit A, Page 13 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 15 of 44 Page ID #:15 Exhibit A, Page 14 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 16 of 44 Page ID #:16 Exhibit A, Page 15 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 17 of 44 Page ID #:17 Exhibit A, Page 16 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 18 of 44 Page ID #:18 Exhibit A, Page 17 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 19 of 44 Page ID #:19 Exhibit A, Page 18 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 20 of 44 Page ID #:20 Exhibit A, Page 19 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 21 of 44 Page ID #:21 EXHIBIT B Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 22 of 44 Page ID #:22 Exhibit B, Page 20 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 23 of 44 Page ID #:23 Exhibit B, Page 21 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 24 of 44 Page ID #:24 Exhibit B, Page 22 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 25 of 44 Page ID #:25 Exhibit B, Page 23 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 26 of 44 Page ID #:26 Exhibit B, Page 24 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 27 of 44 Page ID #:27 Exhibit B, Page 25 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 28 of 44 Page ID #:28 Exhibit B, Page 26 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 29 of 44 Page ID #:29 Exhibit B, Page 27 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 30 of 44 Page ID #:30 Exhibit B, Page 28 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 31 of 44 Page ID #:31 Exhibit B, Page 29 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 32 of 44 Page ID #:32 Exhibit B, Page 30 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 33 of 44 Page ID #:33 Exhibit B, Page 31 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 34 of 44 Page ID #:34 Exhibit B, Page 32 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 35 of 44 Page ID #:35 Exhibit B, Page 33 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 36 of 44 Page ID #:36 Exhibit B, Page 34 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 37 of 44 Page ID #:37 Exhibit B, Page 35 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 38 of 44 Page ID #:38 Exhibit B, Page 36 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 39 of 44 Page ID #:39 Exhibit B, Page 37 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 40 of 44 Page ID #:40 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 41 of 44 Page ID #:41 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 42 of 44 Page ID #:42 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 43 of 44 Page ID #:43 Case 8:11-cv-01264-CJC -RNB Document 1 Filed 08/23/11 Page 44 of 44 Page ID #:44 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ATTACHMENT TO CIVIL COVER SHEET CareFusion 303, Inc. v. B. Braun Medical, Inc. United States District Court for the Central District of California FOLEY & LARDNER LLP ATTORNEYS AT LAW 3579 VALLEY CENTRE DR., SUITE 300 SAN DIEGO, CALIFORNIA 92130-3302 TELEPHONE: 858.847.6700 FACSIMILE: 858.792.6773 AMAR L. THAKUR CA Bar No. 194025
[email protected] SHAWN E. MCDONALD CA Bar No. 237580
[email protected] MEGAN E. O'SULLIVAN CA Bar No. 273052
[email protected] ATTORNEYS FOR PLAINTIFF CAREFUSION 303, INC. ATTACHMENT TO CIVIL COVER SHEET DLMR_928718.1